SEC 13F Intelligence

Arch Venture Management, LLC / SYRSEUR

Arch Venture Management, LLC’s Syros Pharmaceuticals Inc Com New Position

Does Arch Venture Management, LLC own Syros Pharmaceuticals Inc Com New (SYRSEUR)? Not currently — the last reported position was 200.0K shares worth $2M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q3 2020
Shares
200.0K
% of Portfolio
+8.83%
Quarters Held
5
position exited

Position History SYRSEUR

Reported value by quarter
Q3 ’19: $40MQ3 ’19Q4 ’19: $23MQ4 ’19Q1 ’20: $18MQ1 ’20Q2 ’20: $4MQ2 ’20Q3 ’20: $2MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2020200.0K$2M+8.83%
Q2 2020400.0K$4M+14.35%
Q1 20203.06M$18M+30.67%
Q4 20193.31M$23M+29.84%
Q3 20193.86M$40M+43.80%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Arch Venture Management, LLC’s full portfolio or all institutional holders of SYRSEUR.